Axel Mark Inc.
Accel Mark Co., Ltd. Notice Regarding Issuance of New Shares via Third-Party Allotment and Conclusion of Committed-Term Loan Facility
Revenue increased 33.8% YoY to 1,016.352 million yen, operating loss of 381 million yen, ordinary loss of 413 million yen, and net loss attributable to owners of the parent of 530 million yen for the quarter. Secured funding by issuing new shares totaling 900 million yen and entering into a committed-term loan facility of 3,000 million yen. Change in consolidated scope, including ConvaNo becoming the new parent company, is also taking place.
Key Figures
- Revenue: 1,016,352 thousand yen (YoY +33.8%)
- Operating loss: △381,474 thousand yen
- Ordinary loss: △413,220 thousand yen
- Net income attributable to owners of the parent (quarter): △530,751 thousand yen
- New share issue amount: 900,000,000 yen
- Credit facility limit: 30,000,000,000 yen
- Issued shares: 45,000,000 shares
AI要約
Overview of Performance
In the third quarter cumulative, revenue rose sharply to 1,016.6 million yen year on year, while operating, ordinary, and net losses widened. Financial restructuring is underway to secure funds for investments in the healthcare domain. Funding framework was secured by issuing new shares totaling 900 million yen and by a committed facility loan of 3,000 million yen. This aims to improve the financial foundation, and organizational restructuring making ConvaNo the new parent is also progressing.
Outlook and Impact on Capital Policy
No full-year earnings forecast was incorporated in this results release, and there is potential for revisions considering fourth-quarter performance trends. While the funding base has significantly improved due to the third-party allotment and loan facility, continued business conditions such as exclusion of consolidated subsidiaries and becoming a listed group company require careful attention. Growth strategy including healthcare M&A and investments is pursued to stabilize earnings.
Accel Mark Co., Ltd.
Company overview · Stock price · Financial data · All IR
